CMTM4 and renal cell carcinoma: As the most conserved member of the CMTM family, CMTM4 is frequently downregulated and regulates cell growth and cell cycle to exert tumor-suppressing activity in several cancers, including RCC, by inhibiting the AKT and ERK pathways [12, 13].